ロード中...
Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
While the initial treatment of non-small cell lung cancer (NSCLC) usually relies on surgical resection followed by systemic cytotoxic chemotherapy and/or radiation therapy, recent advances in understanding of NSCLC biology and immunology have spurred the development of numerous targeted therapies. I...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5328134/ https://ncbi.nlm.nih.gov/pubmed/28260909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S104343 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|